Physician profile
Moriah Davis
NPI 1568013415
$3,710.39
in general payments reported to CMS, 2019-2025
20 companies · $2,957 in 2025
The $2,957 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $46.76 · 2023: $166 · 2024: $541 · 2025: $2,957.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,423 · Education: $240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,423.14 |
| Education | $240.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $520.20 | 2025 | |
| Janssen Biotech, INC. | $413.14 | 2024-2025 | Tremfya, Simponi, Simponi Aria |
| Regeneron Healthcare Solutions, INC. | $399.02 | 2025 | Dupixent |
| Lilly USA, LLC | $379.48 | 2023-2025 | Taltz, Ebglyss, Mounjaro |
| Ucb, INC. | $315.77 | 2025 | Bimzelx |
| Sun Pharmaceutical Industries INC. | $282.89 | 2025 | |
| Pfizer INC. | $236.93 | 2025 | |
| Novartis Pharmaceuticals Corporation | $176.59 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $169.69 | 2025 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $166.99 | 2025 | Zoryve |
| Novo Nordisk INC | $130.48 | 2024 | Wegovy |
| Vivus LLC | $118.71 | 2023 | Qsymia |
| Genzyme Corporation | $90.82 | 2025 | |
| Incyte Corporation | $75.92 | 2024-2025 | Opzelura |
| Galderma Laboratories, L.P. | $53.66 | 2025 | Nemluvio |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $46.76 | 2021 | |
| Amgen INC. | $42.21 | 2025 | Otezla |
| Leo Pharma INC. | $41.23 | 2025 | Adbry |
| Glaxosmithkline, LLC. | $28.35 | 2024 | Trelegy Ellipta |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $21.55 | 2025 | Jublia, Cabtreo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moriah Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.